ASM International N.V. (ASM.AS): analysis and signal as of September 6, 2026

Published on September 6, 2026 at 18:25 · Updated on September 6, 2026 at 18:25 · by Aurélien Ambert, QDNA

Exchange : Euronext Amsterdam · Sector : Semiconductors, Atomic Deposition and Epitaxy

In short

ASM International N.V. (ASM.AS) presents a moderate signal, with a vote of 2/2 and a score of 1.5. Results and the business outlook support the thesis, while the technical correction and fragile flows limit the strength of the signal.

Current signal: moderate (vote 2/2)
Deterministic score: +1.5 → signal expected by the scale : moderate (September 10, 2026)
Layers: fundamentals : positive, price : positive, risks : positive

Triggered rules

Rule	Weight
favors a high and durable return on invested capital (ROIC), a marker of a lasting moat	+2.0
penalizes a PEG above 2, the anticipated growth is overpaid (overvalued fast grower)	-1.5
moderately favors an asset with robust operating profitability (RMW factor), cross-check with accounting quality (possible manipulation)	+0.5
moderately favors a positive 12-1 month momentum (tailwind), BUT guardrail: costly rotation, long-term reversal, momentum crashes, a conviction signal, not a rotation trigger	+0.5

Thesis

ASM International is an equipment manufacturer specializing in atomic layer deposition (ALD) and epitaxy, characterized by barriers to access, a high return on invested capital and a PEG of 0,9. The macroeconomic regime favors its sector. However, the stock is undergoing a short correction below its MM50, while remaining above its MM200. Fragile retail investor flows, a risk regime described as complacent and the slope of the yield curve constitute sources of vulnerability for its valuation.

Bull case

Q2 2026 results exceed the company's forecasts, with revenue of 1 003 M EUR and EBITDA of 255 M EUR. S2 2026 forecasts indicate EBITDA > 470 M EUR. The 150 M EUR share repurchase program and the PEG of 0,9 complement this argument. The semiconductor sector also benefits from the expansionary macroeconomic regime, to which the analysis assigns a bullish weighting of 0,58.

Bear case

The Cboe risk regime is described as complacent, with a VIX9D/VIX3M ratio of 11,97/17,61, a slope of -32 % and a put-to-call ratio of 0,76. These indicators reflect limited hedging and vulnerability to a sentiment shock. The slope of the yield curve (+0,48 pt EA) weighs on growth multiples. Retail investor flows show a contrast between the change outside the trading session of +18,9 bp/j and the change of -6,4 bp/j during the session. Volume is low (-49 % relative to the 30-day average), while the decline of 16 % since the T2 report on 04/08/2026 accompanies the observation that growth is already priced in by the market.

Scenarios

The bullish scenario is assigned a probability of 40 %. The central scenario is also assigned a probability of 40 %. The bearish scenario is weighted at 20 %, with a maximum loss of -35 % indicated in the analysis.

Risks

The identified risks concern the sensitivity of growth multiples to the yield curve, limited hedging against a sentiment shock and fragile flows during the trading session. Weak volume and the correction below the MM50 temper the interpretation of operating results, while the stock remains above its MM200.

Upcoming catalysts

Date	Description
October 28, 2026	Third quarter 2026 results with order book publication
November 24, 2026	Capital markets day in New York

Signal history (last 12 months)

Date	Signal	New fact
September 6, 2026	moderate (2/2)	Unchanged.
September 1, 2026	moderate (single draw, outside the three-draw protocol)	unchanged

Frequently asked questions

Why does the signal remain moderate despite operating results?

The moderate signal reflects the coexistence of results exceeding forecasts and factors contributing to stock market fragility. Q2 2026 revenue and EBITDA support the thesis, as does the S2 2026 outlook. However, the correction below the MM50, low volumes and the complacency regime limit the strength of these favorable factors.

What factors support the bullish thesis on ASM International?

The bullish thesis rests on specialization in ALD and epitaxy, barriers to access and a high return on invested capital. It is also supported by a PEG of 0,9, Q2 2026 results exceeding forecasts, a 150 M EUR share repurchase program and a sector favored by the expansionary macroeconomic regime.

What do flows and risk indicators reveal?

Flows show an increase outside the trading session of +18,9 bp/j and a decline during the session of -6,4 bp/j, accompanied by volume that is -49 % below the 30-day average. The analysis thus describes retail investor flows as fragile. The complacency regime also indicates limited hedging, which could heighten vulnerability to a sentiment shock.

Sources

No official filing is attached to this stock in the database to date. The figures quoted above come from an automated arbitration: they have not been re-checked one by one.

Automated AI analysis: limitations and transparency

This content is an automated analysis produced using artificial intelligence. Personal analysis for information purposes — no personalised investment advice. MMR content consists of general research. It does not take account of your financial circumstances, objectives or risk tolerance. Data, analyses and results, including those produced using artificial intelligence, may contain errors, be incomplete or become outdated. No return or outcome is guaranteed. All investments carry a risk of partial or total loss of capital. Past performance and simulations do not predict future results. Before making any decision, check information against original sources and, where necessary, consult an authorised professional. You remain responsible for your investment decisions. This notice does not exclude or limit any liability that cannot legally be excluded or limited.
Tool and analysis: QDNA, Aurélien Ambert.
Analysis (arbitration) completed on September 6, 2026; this page was completed on September 6, 2026 at 18:25 (UTC).
Interests: no position in the stock analysed (ASM.AS) is recorded in the data consulted on September 12, 2026 (UTC). This does not confirm the absence of holdings or other interests. The situation at the analysis publication date has not been reconstructed.
This declaration covers only recorded positions in this stock; it is not an exhaustive verification of other interests or remuneration.
Methodology: analysis chain, score formula and scale described on the public methodology page.
Analysis horizon: 2035.